Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (28 February 2015)
Special Issue Editor
Interests: RNA biology; regulatory RNA molecules; extracellular vesicles; identification of genetic defects in inherited diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The journals Molecules and Pharmaceuticals will be jointly publishing a Special Issue covering the topic, “Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases”, and I would like to invite you to make submissions addressing the following interesting topics regarding muscular dystrophy.
Muscular dystrophies are a heterogeneous group of inherited diseases with different molecular basis, but sharing similar clinical features and dystrophic changes. Although, substantial ground has been covered on the understanding of several muscular dystrophies, more research efforts would be beneficial in this direction. Similarly, there are several pre-clinical and clinical attempts aiming at the therapy of muscular dystrophies, such as genetic, cellular, and pharmacological. It is certain that in the future, new approaches will be developed whereby optimization of current methods will be carried out.
The purpose of this Special Issue is to host research and review papers on the molecular understanding of muscular dystrophies and methods to cure them.
Prof. Dr. Leonidas A. Phylactou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Muscular dystrophy
- Muscle
- Gene
- Mutation
- inherited
- pathogenesis
- gene therapy
